Hyperion DeFi (NASDAQ:HYPD) Shares Down 2.2% – Here’s What Happened

Posted by Brenda Bartman on Aug 8th, 2026

Hyperion DeFi, Inc. (NASDAQ:HYPD – Get Free Report)’s share price dropped 2.2% on Thursday . The stock traded as low as $2.60 and last traded at $2.67. 108,444 shares changed hands during mid-day trading, a decline of 52% from the average daily volume of 226,529 shares. The stock had previously closed at $2.73.

Analyst Ratings Changes

HYPD has been the subject of a number of research reports. Cantor Fitzgerald lifted their target price on shares of Hyperion DeFi from $4.00 to $6.60 and gave the company an “overweight” rating in a research note on Wednesday, July 1st. Zacks Research raised shares of Hyperion DeFi from a “strong sell” rating to a “hold” rating in a research note on Tuesday, July 14th. Weiss Ratings upgraded Hyperion DeFi from a “sell (e+)” rating to a “sell (d-)” rating in a report on Wednesday, June 24th. Finally, Chardan Capital reduced their price objective on Hyperion DeFi from $8.25 to $7.30 and set a “buy” rating for the company in a research report on Monday, June 8th. Two research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, Hyperion DeFi currently has a consensus rating of “Hold” and an average target price of $6.95.

Check Out Our Latest Research Report on Hyperion DeFi

Hyperion DeFi Stock Performance

The stock has a market cap of $40.93 million, a P/E ratio of -0.27 and a beta of 2.53. The firm’s 50-day moving average is $2.99 and its two-hundred day moving average is $3.36. The company has a quick ratio of 1.97, a current ratio of 1.97 and a debt-to-equity ratio of 0.12.

Insider Buying and Selling at Hyperion DeFi

In other Hyperion DeFi news, insider Hyunsu Jung purchased 7,000 shares of the business’s stock in a transaction dated Monday, June 1st. The shares were acquired at an average price of $3.70 per share, for a total transaction of $25,900.00. Following the acquisition, the insider owned 1,384,676 shares of the company’s stock, valued at $5,123,301.20. This trade represents a 0.51% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Corporate insiders own 7.50% of the company’s stock.

Hedge Funds Weigh In On Hyperion DeFi

Several hedge funds have recently bought and sold shares of HYPD. Nations Financial Group Inc. IA ADV acquired a new stake in shares of Hyperion DeFi in the fourth quarter worth about $40,000. Sanctuary Advisors LLC acquired a new position in shares of Hyperion DeFi during the 4th quarter valued at about $38,000. Investment House LLC bought a new position in shares of Hyperion DeFi in the 4th quarter valued at approximately $166,000. Geode Capital Management LLC bought a new position in shares of Hyperion DeFi in the 4th quarter valued at approximately $214,000. Finally, Focus Partners Advisor Solutions LLC bought a new position in shares of Hyperion DeFi in the 4th quarter valued at approximately $221,000. 25.84% of the stock is owned by institutional investors and hedge funds.

About Hyperion DeFi

(Get Free Report)

Eyenovia, Inc, an ophthalmic technology company, engages in the development of therapeutics based on its proprietary microdose array print platform technology. The company's product candidates include MicroPine, which is in Phase III clinical development program with indications for pediatric myopia progression (near-sightedness); MicroLine, which is in Phase III clinical development program with indications for the improvement in near vision in people with presbyopia; and Mydcombi, which is in Phase III clinical development program with indications for pharmaceutical mydriasis.